Dr Samuel JK Abraham: Brief Profile
Location:          Yamanashi-ken, Japan
Profession:       Clinician Scientist
Discipline:         Medicine
Specialization:  Cardiac Surgery; Regenerative Medicine

Completed primary medical degree in Tirunelveli Medical College Affiliated to Madurai Kamaraj University, India, in 1992. After a year in Pediatric surgery training, joined Yamanashi Medical University, Japan in April 1994. Finished post-graduate training in Cardiac surgery in 1999 and got PhD. Since then, with the Division of Pediatric Cardiac Surgery, Yamanashi University-Faculty of Medicine, Japan till date.

Lecturer, Centre for advancing clinical research, Yamanashi University; 2012~ till date
   • Fellow, Royal College of Physicians, London (FRCP-L)
   • Fellow, Indian Association of Cardiothoracic Surgeons (FIACTS)

Started research in stem cells under the Nichi-In consortium, Tokyo, Japan in 2000

Head, R&D, Co-Founder & Director, GN Corporation Co Ltd., Kofu, Japan.(www.gncorporation.com)-2002 Till Date

Founder & Director, Nichi-In Centre for Regenerative Medicine (NCRM), India; 2005~ till date
(Admin Office: Chennai, India; R & D Lab: @ SoulSynergy, Mauritius) – www.ncrm.org

Distinguished Visiting Professor Award by the University of Toronto, CIHR TPRM 2012 & 2018.

Adjunct Faculty, INDICASAT, Panama, April 2012

Visiting Professor, Tamilnadu Dr MGR Medical University, India (2010-2015)

Member, Scientific Board, International Stem Cell Academy (www.stemcell-academy.com/scientific-board/)

Accomplishments :

1. Tech-transfer of cell based therapies for male urethral stricture from India to Japan
2. Immune cell therapies (AIET) – Tech-transfer from Japan to Vietnam, Malaysia and Mauritius
3. World’s first ‘An eye for Eyes’ project to clinic; Help solve global donor corneal shortage
4. Unraveling the potential of a novel beta-glucan as a drug for Duchenne Muscular Dystrophy (DMD); US-FDA granted Orphan Drug Designation (ODD) & Rare Pediatric Drug Designation (RPD)
5. A pioneering feat in cell therapy unravelling the mechanisms of regeneration through paracrine effect combined with cell engraftment yielding restoration of urothelial integrity in clinical settings.

Publications :

1. Regenerative Medicine Immunology & Nutritional sciences: Click here
2. Cardiothoracic and Vascular Surgery.
Click here

Interests :

1. Translation of bench-side technologies for in vitro cell culture and tissue engineering using nanomaterials and polymers to the bed-side
2. Studying the complexity of physico-chemical-biological interactions by way of reproducing in vitro biomimicking systems with nanomaterials and environments
3. Reversal of senescence, healthy aging in vitro & in vivo through varying physico-chemical-biological environments including zero-gravity of the outer space
4. Development and evolution of immune system, poly-extremo tolerance and adaptability across the ladder of phylogeny
• Gut microbiome, immune balancing & immunomodulation, pre-biotics
• Gut microbiome, immune systems, pre-biotics and metabolic syndrome
• Gut-brain axis, misfolding of alpha-synuclein, and their implications on neurodevelopmental and neurodegenerative diseases

Projects pursued:

Corneal limbal stem cells, endothelial progenitors, (cesbank.org; eyecore.org)

  1. Hybrid Artificial Corneal Prosthesis (hybridcornea.org)
  2. Hepatic progenitors for drug toxicology screening,
  3. Natural killer cell based immunotherapy for cancer; viral infections, (www.immunotreatment.org)
  4. Human monoclonal antibodies for cancer,
  5. Cell based therapies for anti-aging,
  6. In vitro expansion of human hematopoietic stem cells,
  7. Tissue engineering of human chondrocytes(www.eels-talc.org),
  8. Nanomaterial based scaffolds for cell culture and tissue engineering,
  9. Dental stem cells & their applications in regenerative medicine,
  10. Autologous buccal mucosal cell based therapies for male urethral stricture (www.beeshaus.org),
  11. Novel yeast strain produced poly-saccharides for human health and aging (www.nichiglucan.com)

Patents (applied/granted):

  1. A method for cultivating cells derived from corneal limbal tissue.
  2. Corneal endothelial precursor cell transplantation methodology employing a Nanocomposite gel sheet.
  3. A novel method of cryopreservation of various types of cells
  4. Influenza neutralizing antibody and method for screening the same
  5. Buccal epithelium Expanded and Encapsulated in Scaffold-Hybrid Approach to Urethral Stricture (BEES-HAUS)
  6. Enhancement of cells and increased NO production in microgravity
  7. Immune system enhancement and modulation in tackling viral infections and carcinogenesis
  8. Molecules of significance in curtailing organ fibrosis
  9. Method of beneficial reconstitution of Gut microbiome in tackling neurological illnesses
  10. Method to activate endogenous melatonin in children with Autism Spectrum Disorder

Blogs :

Nature Biotech Blog | Nature Bioengineering Community

Other Websites :

http://www.metaniche.org

http://www.chennaicellcluster.org

http://www.angrennut.com